Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Maintenance doses keep treatment working after the initial improvement, because stopping early often allows symptoms to return as a child's body, weight, and growth stage change. During growth spurts, a dose that once controlled the condition can become too low, which is why ongoing monitoring and dose adjustments help prevent relapse and setbacks. Skipping or tapering too soon is one of the most common reasons progress is lost, and regaining control can take longer than maintaining it. There are several important factors to consider, including timing, weight changes, and warning signs of relapse, so see below to understand more. If symptoms seem to be creeping back or you are unsure whether a dose is still doing its job, a free, instant, online symptom check can help you clarify what may be happening and decide on your next steps quickly.
Last reviewed for medical accuracy: 08/18/2026
Why Maintenance Doses Are Important Throughout Growth: Preventing Relapse
Children diagnosed with nutritional rickets often show dramatic improvement once they begin treatment with therapeutic doses of vitamin D and calcium. Yet clinical experience and research tell us that stopping supplements too soon can allow rickets to return. Rickets recurrence after stopping supplements is not rare—continued intake of maintenance doses plays a crucial role in safeguarding growing bones and preventing relapse, especially during rapid phases of growth.
What Is Rickets and Why Does It Relapse?
Rickets is a condition in which bones soften and weaken because of inadequate mineralization, most commonly from vitamin D deficiency. During infancy and childhood, bones are constantly remodeling; without sufficient vitamin D and calcium, this process falters. Typical signs include bowed legs, delayed growth, and bone pain. Once the obvious signs disappear with treatment, families may assume the risk has passed. In truth, the underlying tendency toward low vitamin D persists until dietary, lifestyle, and physiological needs are fully met—often well past the point where symptoms vanish.
Key Reasons Rickets Can Come Back
• Continued high demand in growth spurts. Rapidly lengthening bones require a steady supply of minerals.
• Seasonal or lifestyle changes. Reduced outdoor time or dietary shifts (e.g., elimination diets) can lower vitamin D and calcium intake.
• Incomplete repletion of body stores. Initial treatment doses restore blood levels but may not refill reserves in fat and muscle.
• Unrecognized risk factors. Darker skin, limited sun exposure, or certain chronic illnesses can prolong deficiency.
Clinical Evidence Behind Maintenance Dosing
Multiple guidelines from pediatric and endocrinology societies emphasize maintenance therapy to prevent relapse:
• A 2016 systematic review in the Journal of Clinical Endocrinology & Metabolism found that children who stopped vitamin D supplementation after treatment had a 30–40% chance of rickets recurrence within 1–2 years, compared to <5% when low-dose maintenance was continued.
• The American Academy of Pediatrics recommends ongoing vitamin D intake of 400–1,000 IU daily (based on age and risk), even after signs of rickets resolve, to maintain serum levels above 30 ng/mL.
• The Endocrine Society’s 2011 guidelines advise up to 2,000 IU/day for high-risk children during periods of rapid growth or limited sun exposure.
How Maintenance Doses Work
Replenishing Reserves
– Initial treatment doses correct immediate deficiency.
– Maintenance doses gradually build and sustain vitamin D stored in fat and muscle, a buffer during times of low intake or sun exposure.
Supporting Steady Bone Mineralization
– Consistent levels of vitamin D and calcium keep bone remodeling on track.
– Prevents micro-defects from accumulating as bones lengthen.
Adapting to Growth Needs
– Supplements can be adjusted for age, weight, season, and latitude.
– Flexibility ensures that children in northern climates or with darker skin maintain adequate levels year-round.
Recommended Maintenance Strategies
While individual needs vary, the following framework, drawn from established guidelines, offers a starting point. Always tailor doses in consultation with a healthcare provider.
• Vitamin D Intake
– Infants (0–12 months): 400 IU daily after initial treatment course
– Children (1–8 years): 600–1,000 IU daily
– Older children/adolescents (9–18 years): 600–1,500 IU daily, up to 2,000 IU in high-risk cases
• Dietary Calcium
– Aim for 700–1,300 mg per day through milk, yogurt, cheese, fortified plant milks, or supplements if needed.
– Balance excessive calcium (>2,500 mg/day) to avoid kidney strain.
• Sunlight Exposure
– 10–20 minutes of midday, unprotected sun on arms and legs several times a week—adjusted for skin type and local UV index.
– Use cautious sun protection practices; avoid burns.
• Regular Monitoring
– Serum 25(OH)D, calcium, and alkaline phosphatase every 6–12 months or more often in high-risk children.
– X-rays only if clinical signs reappear or labs worsen.
Signs of Possible Relapse
Stay alert to subtle changes—early detection keeps treatment simple:
• Bone pain, particularly in legs or lower back
• Difficulty walking or delays in milestones (toddling, running)
• Swollen wrists or ankles
• New deformities (bowing of legs, knock knees)
• Growth slowing or dropping off percentile charts
Lifestyle and Dietary Support
Beyond supplements, a holistic approach maximizes bone health:
• Offer a balanced diet rich in dairy or fortified alternatives, oily fish, egg yolks, and vitamin D–fortified cereals.
• Encourage safe outdoor play to boost natural vitamin D synthesis.
• Monitor for conditions that affect absorption—cystic fibrosis, celiac disease, inflammatory bowel disease—and treat underlying issues.
• Limit soda and high-phosphorus foods that can disrupt calcium balance.
Addressing Parental Concerns
It’s natural to worry about daily pills or drops, but here’s why consistency matters—and how to make it easier:
• Create routines. Link supplement time to meals or bedtime.
• Use flavored drops or chewable tablets suited to your child’s age.
• Involve older children in choosing their supplement form.
• Track doses in a simple app or chart.
Rickets recurrence after stopping supplements is a preventable setback. Maintenance doses are not a lifetime sentence—they’re a bridge to strong, healthy bones during the most critical years of growth. By following evidence-based dosing, regular monitoring, and dietary plus lifestyle support, families can dramatically reduce the chance of relapse and the need for more intensive treatment down the road.
If you notice any signs of bone pain, growth delays, or changes in posture, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) to help guide your next steps. And always speak to a doctor about anything that could be life threatening or serious. Maintenance therapy tailored to your child’s unique needs, under a healthcare provider’s guidance, is the best safeguard against rickets returning—and the key to giving growing bones the lasting support they deserve.
(References)
* Burchert A, Bug G, Fritz LV, Finke J, Stelljes M, Röllig C, Wollmer E, Wäsch R, Bornhäuser M, Berg T, Lang F, Ehninger G, Serve H, Zeiser R, Wagner EM, Kröger N, Wolschke C, Schleuning M, Götze KS, Schmid C, Crysandt M, Eßeling E, Wolf D, Wang Y, Böhm A, Thiede C, Haferlach T, Michel C, Bethge W, Wündisch T, Brandts C, Harnisch S, Wittenberg M, Hoeffkes HG, Rospleszcz S, Burchardt A, Neubauer A, Brugger M, Strauch K, Schade-Brittinger C, Metzelder SK. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN). J Clin Oncol. 2020 Sep 10;38(26):2993-3002. doi: 10.1200/JCO.19.03345. Epub 2020 Jul 16. PMID: 32673171.
* Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY, South China Breast Cancer Group (SCBCG). Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial. JAMA. 2021 Jan 5;325(1):50-58. doi: 10.1001/jama.2020.23370. PMID: 33300950; PMCID: PMC7729589.
* Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, Ravandi F, Sayar H, Jang JH, Porkka K, Selleslag D, Sandhu I, Turgut M, Giai V, Ofran Y, Kizil Çakar M, Botelho de Sousa A, Rybka J, Frairia C, Borin L, Beltrami G, Čermák J, Ossenkoppele GJ, La Torre I, Skikne B, Kumar K, Dong Q, Beach CL, Roboz GJ, QUAZAR AML-001 Trial Investigators. Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. PMID: 33369355.
* Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN. Diagnosis and Management of Multiple Myeloma: A Review. JAMA. 2022 Feb 1;327(5):464-477. doi: 10.1001/jama.2022.0003. PMID: 35103762.
* Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15. PMID: 35569035.
* Liu Y, Jin K, Yang Y, Yang A. Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis. Eur J Intern Med. 2024 Sep;127:63-73. doi: 10.1016/j.ejim.2024.06.006. Epub 2024 Jun 12. PMID: 38871563.
* Sabakhtarishvili G, Ansari A, Tabbara IA. Maintenance Therapy in Acute Myeloid Leukemia. Am J Clin Oncol. 2025 Jan 1;48(1):38-43. doi: 10.1097/COC.0000000000001140. Epub 2024 Sep 6. PMID: 39238120.
* Roboz GJ, Canaani J. How I use maintenance therapy in acute myeloid leukemia. Blood. 2025 Mar 20;145(12):1273-1281. doi: 10.1182/blood.2024024010. PMID: 39374534.
* ACCURE Study Group. Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial. Lancet Gastroenterol Hepatol. 2025 Jun;10(6):550-561. doi: 10.1016/S2468-1253(25)00026-3. Epub 2025 Apr 11. PMID: 40228513; PMCID: PMC12062198.
* Ho AHY, Choi D, Mathew AJ, McDermott A, Fine Z, Fear E, Choi NK, Cohen RD, Dalal SR, Pekow J, Krugliak Cleveland N, Rubin DT. Real-world Experience of Upadacitinib Reinduction and High-dose Maintenance Therapy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2026 Mar;24(3):763-771. doi: 10.1016/j.cgh.2025.07.042. Epub 2025 Aug 7. PMID: 40782945.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.